Axogen, Inc. Insider Trading for December 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Axogen, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Axogen, Inc. for December 2020.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 31 2020 | LECT | Axogen, Inc. | Donovan Michael Patrick | VP Operations | Sell | S | 17.48 | 1,733 | 30,293 | 26,029 | 27.8 K to 26 K (-6.24 %) |
Dec 30 2020 | LECT | Axogen, Inc. | DeVinney Erick Wayne | VP, Clinical&Transl ... | Sell | S | 17.81 | 371 | 6,608 | 63,240 | 63.6 K to 63.2 K (-0.58 %) |
Dec 30 2020 | LECT | Axogen, Inc. | DeVinney Erick Wayne | VP, Clinical&Transl ... | Grant | A | 0.00 | 1,500 | 0 | 63,611 | 62.1 K to 63.6 K (+2.42 %) |
Dec 30 2020 | LECT | Axogen, Inc. | Donovan Michael Patrick | VP Operations | Sell | S | 17.81 | 567 | 10,098 | 27,762 | 28.3 K to 27.8 K (-2.00 %) |
Dec 30 2020 | LECT | Axogen, Inc. | Donovan Michael Patrick | VP Operations | Grant | A | 0.00 | 2,300 | 0 | 28,329 | 26 K to 28.3 K (+8.84 %) |
Dec 30 2020 | LECT | Axogen, Inc. | Freitag Gregory Gene | Director | Sell | S | 17.81 | 916 | 16,314 | 248,345 | 249.3 K to 248.3 K (-0.37 %) |
Dec 30 2020 | LECT | Axogen, Inc. | Freitag Gregory Gene | Director | Sell | S | 17.81 | 916 | 16,314 | 248,345 | 249.3 K to 248.3 K (-0.37 %) |
Dec 30 2020 | LECT | Axogen, Inc. | Freitag Gregory Gene | Director | Grant | A | 0.00 | 2,300 | 0 | 249,261 | 247 K to 249.3 K (+0.93 %) |
Dec 30 2020 | LECT | Axogen, Inc. | Freitag Gregory Gene | Director | Grant | A | 0.00 | 2,300 | 0 | 249,261 | 247 K to 249.3 K (+0.93 %) |
Dec 30 2020 | LECT | Axogen, Inc. | MARIANI PETER J | Chief Financial Off ... | Sell | S | 17.81 | 1,293 | 23,028 | 10,376 | 11.7 K to 10.4 K (-11.08 %) |
Dec 30 2020 | LECT | Axogen, Inc. | MARIANI PETER J | Chief Financial Off ... | Grant | A | 0.00 | 5,250 | 0 | 11,669 | 6.4 K to 11.7 K (+81.79 %) |
Dec 30 2020 | LECT | Axogen, Inc. | Scopelianos Angelo | VP Research & Devel ... | Sell | S | 17.81 | 567 | 10,098 | 5,529 | 6.1 K to 5.5 K (-9.30 %) |
Dec 30 2020 | LECT | Axogen, Inc. | Scopelianos Angelo | VP Research & Devel ... | Grant | A | 0.00 | 2,300 | 0 | 6,096 | 3.8 K to 6.1 K (+60.59 %) |
Dec 30 2020 | LECT | Axogen, Inc. | Zaderej Karen L. | CEO | Sell | S | 17.81 | 3,500 | 62,335 | 674,099 | 677.6 K to 674.1 K (-0.52 %) |
Dec 30 2020 | LECT | Axogen, Inc. | Zaderej Karen L. | CEO | Grant | A | 0.00 | 8,800 | 0 | 677,599 | 668.8 K to 677.6 K (+1.32 %) |
Dec 30 2020 | LECT | Axogen, Inc. | Friedman Mark Louis | VP,Regulatory & Qua ... | Sell | S | 17.81 | 567 | 10,098 | 11,124 | 11.7 K to 11.1 K (-4.85 %) |
Dec 30 2020 | LECT | Axogen, Inc. | Friedman Mark Louis | VP,Regulatory & Qua ... | Grant | A | 0.00 | 2,300 | 0 | 11,691 | 9.4 K to 11.7 K (+24.49 %) |
Dec 30 2020 | LECT | Axogen, Inc. | MARTINEZ MARIA D. | Chief Human Resourc ... | Sell | S | 17.81 | 567 | 10,098 | 4,665 | 5.2 K to 4.7 K (-10.84 %) |
Dec 30 2020 | LECT | Axogen, Inc. | MARTINEZ MARIA D. | Chief Human Resourc ... | Grant | A | 0.00 | 2,300 | 0 | 5,232 | 2.9 K to 5.2 K (+78.44 %) |
Dec 30 2020 | LECT | Axogen, Inc. | Billet Isabelle | Chief Strategy and ... | Sell | S | 17.81 | 649 | 11,559 | 9,496 | 10.1 K to 9.5 K (-6.40 %) |
Dec 30 2020 | LECT | Axogen, Inc. | Billet Isabelle | Chief Strategy and ... | Grant | A | 0.00 | 2,300 | 0 | 10,145 | 7.8 K to 10.1 K (+29.32 %) |
Dec 28 2020 | LECT | Axogen, Inc. | Zaderej Karen L. | CEO | Option Exercise | M | 4.81 | 19,375 | 93,194 | 0 | |
Dec 28 2020 | LECT | Axogen, Inc. | Zaderej Karen L. | CEO | Buy | M | 4.81 | 19,375 | 93,194 | 666,094 | 646.7 K to 666.1 K (+3.00 %) |
Dec 23 2020 | LECT | Axogen, Inc. | Donovan Michael Patrick | VP Operations | Sell | S | 17.19 | 279 | 4,796 | 26,029 | 26.3 K to 26 K (-1.06 %) |
Dec 22 2020 | LECT | Axogen, Inc. | Zaderej Karen L. | CEO | Sell | S | 16.42 | 1,275 | 20,936 | 646,719 | 648 K to 646.7 K (-0.20 %) |
Dec 22 2020 | LECT | Axogen, Inc. | Zaderej Karen L. | CEO | Grant | A | 0.00 | 3,125 | 0 | 647,994 | 644.9 K to 648 K (+0.48 %) |
Dec 22 2020 | LECT | Axogen, Inc. | DeVinney Erick Wayne | VP, Clinical&Transl ... | Sell | S | 16.42 | 147 | 2,414 | 62,111 | 62.3 K to 62.1 K (-0.24 %) |
Dec 22 2020 | LECT | Axogen, Inc. | DeVinney Erick Wayne | VP, Clinical&Transl ... | Grant | A | 0.00 | 575 | 0 | 62,258 | 61.7 K to 62.3 K (+0.93 %) |
Dec 22 2020 | LECT | Axogen, Inc. | Freitag Gregory Gene | Director | Sell | S | 16.42 | 379 | 6,223 | 245,076 | 245.5 K to 245.1 K (-0.15 %) |
Dec 22 2020 | LECT | Axogen, Inc. | Freitag Gregory Gene | Director | Grant | A | 0.00 | 925 | 0 | 245,455 | 244.5 K to 245.5 K (+0.38 %) |
Dec 22 2020 | LECT | Axogen, Inc. | Donovan Michael Patrick | VP Operations | Sell | S | 16.42 | 96 | 1,576 | 26,308 | 26.4 K to 26.3 K (-0.36 %) |
Dec 22 2020 | LECT | Axogen, Inc. | Donovan Michael Patrick | VP Operations | Grant | A | 0.00 | 375 | 0 | 26,404 | 26 K to 26.4 K (+1.44 %) |
Dec 22 2020 | LECT | Axogen, Inc. | MARIANI PETER J | Chief Financial Off ... | Sell | S | 16.42 | 481 | 7,898 | 6,419 | 6.9 K to 6.4 K (-6.97 %) |
Dec 22 2020 | LECT | Axogen, Inc. | MARIANI PETER J | Chief Financial Off ... | Grant | A | 0.00 | 1,900 | 0 | 6,900 | 5 K to 6.9 K (+38.00 %) |
Dec 22 2020 | LECT | Axogen, Inc. | Friedman Mark Louis | VP,Regulatory & Qua ... | Sell | S | 16.42 | 96 | 1,576 | 8,893 | 9 K to 8.9 K (-1.07 %) |
Dec 22 2020 | LECT | Axogen, Inc. | Friedman Mark Louis | VP,Regulatory & Qua ... | Grant | A | 0.00 | 375 | 0 | 8,989 | 8.6 K to 9 K (+4.35 %) |
Dec 17 2020 | LECT | Axogen, Inc. | DeVinney Erick Wayne | VP, Clinical&Transl ... | Option Exercise | M | 4.81 | 15,000 | 72,150 | 0 | |
Dec 17 2020 | LECT | Axogen, Inc. | DeVinney Erick Wayne | VP, Clinical&Transl ... | Payment of Exercise | F | 16.50 | 4,373 | 72,155 | 61,683 | 66.1 K to 61.7 K (-6.62 %) |
Dec 17 2020 | LECT | Axogen, Inc. | DeVinney Erick Wayne | VP, Clinical&Transl ... | Buy | M | 4.81 | 15,000 | 72,150 | 66,056 | 51.1 K to 66.1 K (+29.38 %) |
Dec 07 2020 | LECT | Axogen, Inc. | Friedman Mark Louis | VP,Regulatory & Qua ... | Option Exercise | M | 3.67 | 3,187 | 11,696 | 0 | |
Dec 07 2020 | LECT | Axogen, Inc. | Friedman Mark Louis | VP,Regulatory & Qua ... | Option Exercise | M | 4.81 | 625 | 3,006 | 0 | |
Dec 07 2020 | LECT | Axogen, Inc. | Friedman Mark Louis | VP,Regulatory & Qua ... | Buy | M | 3.67 | 3,187 | 11,696 | 8,614 | 5.4 K to 8.6 K (+58.72 %) |
Dec 07 2020 | LECT | Axogen, Inc. | Friedman Mark Louis | VP,Regulatory & Qua ... | Buy | M | 4.81 | 625 | 3,006 | 5,427 | 4.8 K to 5.4 K (+13.02 %) |